Ticho Barry's Form 4 filing
Stoke Therapeutics, Inc. (STOK) · filed May 5, 2025
- Accession no.
- 0001415889-25-011940
- Filed
- May 5, 2025
- Trade date
- May 1-2, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $267.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ticho BarryCIK 0001780088 | Officer (CHIEF MEDICAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 1, 2025 | Common Stock | SSaleDisposed | −3,841 | $10.00 | −$38,410 | 56,788 | Direct | |
| May 2, 2025 | Common Stock | SSaleDisposed | −22,790 | $10.03 | −$228,583.7 | 33,998 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.